| AIDS | Acquired immunodeficiency syndrome |
| AZA | Azathioprine |
| CCL | chemokine ligands |
| CD | Crohn’s disease |
| CRP | C-reactive protein |
| CsA | Cyclosporine |
| CTLs | Cytolytic T lymphocytes |
| CXCL | Chemokine platelet activating factor |
| CYC | Cyclophosphamide |
| DM | Dermatomyositis |
| DMARD | Disease-modifying antirheumatic drugs |
| EBV | Epstein-Barr virus |
| EGF | Epidermal growth factor |
| ESR | Westerngren erythrocyte sedimentation rate |
| GCS | Glucocorticoids |
| GM-GSF | Granulocyte macrophage colony stimulating factor |
| GRO | growth-related oncogene |
| HCMV-IgC | Human cytomegalovirus-immunoglobulin-G |
| HGF | hepatocyte growth factor |
| HIV | Human immunodeficiency virus |
| HNC | Head and neck cancers |
| HPV | Human papillomavirus |
| IBD | Inflammatory bowel disease |
| ICAM-1 | Intracellular adhesion molecule 1 |
| IFN-α/γ | Interferon alpha/gamma |
| IL | Interleukin |
| IL-2R | Interleukin 2 receptors |
| MAPK-1 | Mitogen-activated protein kinase-activator protein-1 |
| MCP1 | Monocyte chemoattractant protein 1 |
| MDC | Macrophage derived chemokine |
| MIP-1γ | Macrophage inflammatory protein 1 gamma |
| MMP | matrix metalloproteins |
| MTX | Methotrexate |
| NF-κB | Nuclear factor kappa B |
| NKCs | Natural killer cells |
| NPC | Nasopharyngeal carcinoma |
| PGE2 | Prostaglandin E2 |
| PM | Polymyositis |
| PMN | Polymorphonuclear neutrophils |
| RA | Rheumatoid Arthritis |
| SCCs | Squamous cell carcinomas |
| SIR | Standardized incidence ratio |
| SLE | Systemic lupus erythematous |
| SMD | Standardized mean differences |
| SSc | Systemic sclerosis |
| TAA | Tumor-associated antigens |
| TGF-α/β | Transforming growth factor alpha/beta |
| TNF-α | Tumor necrosis factor alpha |
| TNFi | Tumor necrosis factor inhibitors |
| T-regs | Regulatory T-cells |
| UC | Ulcerative colitis |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| VEGF | vascular endothelial growth factor |